ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Circ_RBM23 knockdown suppresses chemoresistance, proliferation, migration and invasion of sorafenib-resistant HCC cells through miR-338-3p/RAB1B axis

Xu, Chunlin; Sun, Weiwei; Liu, Jinglei; Pu, Haihong; Li, Yinghong*哈尔滨医科大学
Pathology Research and Practice2023-5DOI: 10.1016/j.prp.2023.154435
5阅读
引用收藏
分享

摘要

Background: Circular RNA RNA-binding motif protein 23 (circ_RBM23; ID: hsa_circ_0000524) is a novel regulator in hepatocellular carcinoma (HCC). Herein, we planned to investigate its role in sorafenib resistance in HCC.Method: Levels of circ_RBM23, microRNA (miR)-338-3p, Ras-related GTPase-trafficking protein (RAB1B), Snail and E-cadherin were detected by real-time quantitative PCR and western blotting. Sorafenib resistant (SR) HCC cells (Huh7/SR and SK-HEP-1/SR) were established by acquisition of sorafenib resistance, and cell functions were measured by MTT assay, Edu assay, colony formation assay, apoptosis assay, transwell assay, and in vivo xenograft formation assay. Crosslink between miR-338-3p and circ_RBM23 or RAB1B was confirmed by bioinformatics analysis and dual-luciferase reporter assay.Results: Circ_RBM23 upregulation was discovered in the tissues of SR patients and SR cells, which was accompanied with miR-338-3p downregulation and RAB1B upregulation. The 50% inhibitory concentration (IC50) of sorafenib in SR cells was greatly suppressed by interfering circ_RBM23 or reinforcing miR-338-3p, allied with this was the inhibition of EdU-positive cell rate, colony formation and migration/invasion abilities under sorafenib treatment, as well as the enhancement of apoptotic rate. Moreover, circ_RBM23 inhibition delayed tumor growth of Huh7/SR cells under sorfanib treatment in vivo.Conclusion: Circ_RBM23 promoted chemoresistance, malignant proliferation, migration and invasion of SR HCC cells by modulating miR-338-3p/RAB1B axis.

学科与关键词

关键词
Circ_RBM23MiR-338-3pRAB1BSorafenib resistance
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Pathology Research and Practice
发表日期
2023-05
卷期
第 245 卷
页码
154435
DOI
10.1016/j.prp.2023.154435
语言
ENGLISH
成果收录
SCIE
资助标注
World Medical Association Declaration of Helsinki [H20190528]

作者

  • X

    Xu, Chunlin (第一作者)

    2 · harbin med univ

  • S

    Sun, Weiwei

    harbin med univ

查看全部 5 位作者收起作者
  • L

    Liu, Jinglei

    harbin med univ

  • P

    Pu, Haihong

    harbin med univ

  • L

    Li, Yinghong (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417